AI assistant
CONMED Corp — Director's Dealing 2013
May 30, 2013
31971_dirs_2013-05-30_81235571-97df-4a4e-98ea-0a9ad6c437f1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-05-28
Reporting Person: JONAS DANIEL (VP Legal Affairs, Gen. Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-28 | Common Stock | M | 15000 | $31.40 | Acquired | 21129 | Direct |
| 2013-05-28 | Common Stock | S | 15000 | $34.0005 | Disposed | 6129 | Direct |
| 2013-05-29 | Common Stock | S | 2000 | $33.4102 | Disposed | 4129 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-28 | Options To Purchase Common Stock | $31.40 | M | 15000 | Disposed | 2015-05-17 | Common Stock (15000) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.01. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.36 to $33.51. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
F3: 5 year vesting schedule, 20% vesting each year starting 5/17/2006.